Acute Hepatitis Flashcards

1
Q

Chronic hepatitis occurs when the duration of injury exceeds

A

6 month

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What’s acute hepatitis

A

Acute hepatitis refers to a condition characterized by inflammation of the liver’s parenchyma (the functional tissue of the liver) or direct injury to hepatocytes (liver cells). This leads to abnormal liver function, as indicated by elevated liver enzyme levels. Acute hepatitis is typically diagnosed when the inflammation or injury lasts for less than six months, and the liver function tests return to normal during this period

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How acute liver failure different from acute hepatitis?

A

One of the key points in understanding acute hepatitis is the distinction between acute hepatitis and acute liver failure (ALF). Acute liver failure is a more severe, life-threatening condition where there is rapid deterioration of liver function, usually in a previously healthy individual. This leads to complications such as jaundice, coagulopathy (impaired blood clotting), and hepatic encephalopathy (brain dysfunction caused by liver failure).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Based on data, the most common causes of acute hepatitis and acute liver failure are

A

** viral epatitis** and drug-induced liver injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

. These causes vary by region, with viral hepatitis being more prevalent in low-income regions, while drug-induced liver injury is a significant concern in high-income areas.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

In high-income countries, the incidence of viral hepatitis, particularly Hepatitis A virus (HAV) and Hepatitis B virus (HBV), has dramatically decreased due to vaccination efforts. For instance:
- The incidence of Hepatitis A has reduced by about 95% since the introduction of the hepatitis A vaccine in 1995.
- Similarly, cases of acute hepatitis B have decreased significantly in developed countries since the introduction of the hepatitis B vaccine in 1990.

Despite this, certain groups remain at higher risk for acute hepatitis B, particularly individuals aged 40 and older, due to factors such as:
- Injection drug use
- Multiple sexual partners
- Lack of vaccination

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Aetiology of Acute Hepatitis
Acute hepatitis can be caused by infectious agents such as viruses, bacteria, fungi, and parasites. Among the viruses, there are two primary groups: hepatotropic viruses (those that specifically target the liver) and non-hepatotropic viruses (those that can affect other organs but also involve the liver).

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the examples of hepatotoxic viruses and it’s style of manifestation

A

Hepatotropic Viruses:
1. Hepatitis A Virus (HAV): Usually causes acute, self-limiting liver disease.
2. Hepatitis B Virus (HBV): Can cause both acute and chronic liver disease.
3. Hepatitis C Virus (HCV): More commonly associated with chronic liver disease, though it can present acutely.
4. Hepatitis D Virus (HDV): Requires co-infection with HBV for its replication.
5. Hepatitis E Virus (HEV): Common in resource-poor regions, causing acute liver disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

List examples of non hepatotoxic viruses

A

Non-Hepatotropic Viruses:
1. Epstein-Barr Virus (EBV): Often causes infectious mononucleosis but can also affect the liver.
2. Cytomegalovirus (CMV): A virus that can cause liver inflammation, especially in immunocompromised individuals.
3. Herpes Simplex Virus (HSV): Rarely causes hepatitis, but when it does, it can lead to severe liver injury.
4. Coxsackievirus: Known for causing hand, foot, and mouth disease, but it can also lead to liver inflammation.
5. Adenovirus: Affects the liver mainly in immunocompromised patients.
6. Dengue Virus: A tropical virus that can cause liver damage as part of its systemic effects.
7. COVID-19 (Coronavirus-19): Recent studies show that SARS-CoV-2 can also lead to liver injury, particularly in severe cases.

Bacteria, Fungi, and Parasites: Though less common, these can also cause acute hepatitis, particularly in certain settings or in immunocompromised patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Stages of Alcohol-Related Liver Disease:

A
  • Fatty liver disease: The earliest stage, characterized by fat accumulation in the liver cells due to excessive alcohol consumption.
    • Acute alcoholic hepatitis: Involves liver inflammation due to heavy alcohol use.
    • Alcoholic cirrhosis: The final stage of alcohol-related liver damage, where scar tissue replaces healthy liver tissue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the - Dose-Dependent Toxicity: and non - Dose-Dependent Toxicity:

A
  1. Drugs and Toxins:
    • Dose-Dependent Toxicity:
      • Example: Acetaminophen (paracetamol) overdose is one of the most common causes of drug-induced acute liver failure. The liver metabolizes the drug, producing toxic byproducts at high doses, leading to liver cell damage.
    • Non-Dose-Dependent Toxicity (Idiosyncratic Drug Reactions):
      • Can occur even with normal doses of medications. Common culprits include:
        • Antibiotics: Like amoxicillin-clavulanate, which can lead to liver inflammation.
        • Anticonvulsants: Such as phenytoin and valproate.
        • Antidepressants, statins, NSAIDs (nonsteroidal anti-inflammatory drugs).
        • Herbal and dietary supplements: These can cause unpredictable reactions, sometimes leading to liver toxicity.
      • Other substances include halothane, cyclophosphamide, and methotrexate.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
  • Other Toxins:
    • Mushrooms (e.g., Amanita phalloides, also called the death cap mushroom): Can cause rapid and severe liver damage.
    • Herbal supplements, carbon tetrachloride, yellow phosphorus, and Bacillus cereus toxin can also result in acute liver damage.
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are Some autoimmune and inflammatory conditions can cause acute hepatitis:

A
  1. Autoimmune Hepatitis: The immune system attacks liver cells, leading to inflammation.
  2. Biliary Diseases:
    • Primary biliary cholangitis (PBC): An autoimmune disease affecting the bile ducts, leading to liver damage.
    • Primary sclerosing cholangitis (PSC): Causes inflammation and scarring of the bile ducts.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Ischemic and Vascular Causes

When blood flow to the liver is compromised, it can result in acute hepatitis for example

A

:

  1. Cardiogenic or Distributive Shock: Reduced blood flow (hypoperfusion) to the liver due to shock leads to ischemic hepatitis.
  2. Hypotension: Can also lead to ischemic liver injury.
  3. Heatstroke: Can cause damage to the liver and other organs due to excessive heat.
  4. Drug-Induced Ischemia:
    • Cocaine, methamphetamine, and ephedrine: These stimulants can cause liver ischemia due to vasoconstriction.
  5. Vascular Conditions:
    • Hepatic vein thrombosis (Budd-Chiari syndrome): The veins draining the liver become blocked, causing liver congestion and damage.
    • Sinusoidal obstruction syndrome: Occurs when the small liver vessels become blocked, leading to liver dysfunction.
    • Portal vein thrombosis: Can cause impaired blood flow to the liver, leading to damage.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Lis t Metabolic or Hereditary Causes

A
  1. Nonalcoholic Fatty Liver Disease (NAFLD): Fat accumulation in the liver not caused by alcohol, leading to inflammation and damage.
  2. Hemochromatosis: A genetic condition where excess iron accumulates in the liver, causing damage.
  3. Wilson’s Disease: A hereditary disorder where copper builds up in the liver, leading to toxicity.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pregnancy-Related Conditions

Pregnancy can lead to specific forms of acute liver disease:

A
  1. Preeclampsia: Characterized by high blood pressure and damage to organs, including the liver.
  2. Eclampsia: A severe form of preeclampsia that includes seizures and can cause liver injury.
  3. Acute Fatty Liver of Pregnancy: A rare but serious condition where fat accumulates in the liver during pregnancy, leading to acute liver failure.
  4. HELLP Syndrome: A severe form of preeclampsia involving hemolysis (breakdown of red blood cells), elevated liver enzymes, and low platelet count
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Miscellaneous Causes

Other factors that may contribute to acute hepatitis include:

  1. Malignancy: Certain cancers can affect the liver directly or cause secondary liver damage.
  2. Reye’s Syndrome: A rare condition affecting children, often associated with aspirin use during viral infections, leading to liver damage and brain dysfunction.
  3. Primary Graft Non-Function: After liver transplantation, the new liver may fail to function properly, leading to acute liver failure
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Clinical Features of Acute Hepatitis

The clinical presentation of acute hepatitis varies depending on the cause. Symptoms can range from asymptomatic (with only elevated liver function tests) to severe cases of acute liver failure, which may require liver transplantation.

What are the symptoms from
Mild to severe

A
  • Mild Cases: May present with nonspecific symptoms such as fatigue, nausea, vomiting, abdominal pain, and jaundice.
  • Severe Cases: May lead to coagulopathy, hepatic encephalopathy, and multi-organ failure, necessitating urgent medical intervention.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Patients with acute viral hepatitis typically present with a constellation of symptoms reflecting the body’s reaction to liver inflammation and dysfunction. These symptoms often resemble those seen in general viral infections but are specific to liver involvement:

  • Fever: Low-grade fever is common early in the illness, signaling an infection.
  • Malaise and Fatigue: These non-specific symptoms are often early markers of viral hepatitis, causing a general feeling of unwellness.
  • Loss of Appetite: Many patients report a significant decrease in appetite, which may lead to unintended weight loss.
  • Nausea, Vomiting, and Diarrhea: These gastrointestinal symptoms occur due to liver dysfunction, which impacts digestion and metabolism.
  • Abdominal Pain: Discomfort or pain is usually felt in the right upper quadrant (where the liver is located), due to inflammation or stretching of the liver capsule.

Patients may also report signs that directly indicate impaired liver function:
- Yellowish Discoloration of the Sclera (Icterus) and/or Skin (Jaundice): This occurs due to the buildup of bilirubin, a byproduct of red blood cell breakdown that the liver normally clears.
- Dark-Colored Urine: Caused by excess bilirubin being excreted by the kidneys instead of the liver.
- Light-Colored Stools: This indicates a lack of bile flow into the intestines, also due to impaired liver function

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are some Important Historical Considerations?

When evaluating a patient with suspected acute hepatitis, a thorough history is essential for identifying risk factors and potential causes

A
  • Duration of the Presenting Illness: Acute hepatitis typically manifests within a few weeks to months. Chronic symptoms suggest long-standing liver disease.
  • Travel History: Exposure to certain endemic viral hepatitis types (like hepatitis A or E) in regions with poor sanitation can be a key clue.
  • High-Risk Activities:
    • IV Drug Use: Hepatitis B and C are often spread through shared needles.
    • Alcohol Consumption: Chronic heavy drinking increases the risk of alcoholic hepatitis and liver disease.
    • Sexual History: Hepatitis B and C can be sexually transmitted, so a history of unprotected sex or multiple partners is important to assess.
    • Blood-Product Transfusion: A history of receiving blood transfusions, especially prior to the implementation of strict screening protocols, raises the suspicion of hepatitis C.
    • Recent Food Intake: Hepatitis A can be contracted through contaminated food or water.
  • Family History of Liver Disease: Genetic predisposition to liver disorders (e.g., hemochromatosis, Wilson’s disease) can guide the diagnosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

On Physical Examinations what are the signs you should look for in acute hepatitis
And also in chronic hepatitis/liver failure

A

The physical examination in a patient with acute hepatitis provides clues to the severity of the disease and its etiology:

  • Icterus and Jaundice: Both icterus (yellowing of the eyes) and jaundice (yellowing of the skin) are hallmark signs of liver dysfunction and bilirubin accumulation.
  • Fever: Present in some viral hepatitis cases, indicating the body’s immune response to infection.
  • Hepatomegaly: Enlarged liver can be felt on palpation, often tender, indicating liver inflammation.

In more severe cases or when acute hepatitis progresses to liver failure, the following signs may be seen:
- Signs of Acute Encephalopathy: Due to liver failure, toxins build up in the brain, causing confusion, lethargy, or even coma.
- Seizures: Severe cases with brain involvement may result in seizures.
- Bleeding Diathesis: Liver damage can impair blood clotting factors, leading to spontaneous bleeding or bruising.
- Hypotension: Suggestive of systemic complications like septic shock or liver failure.
- Multi-Organ Failure: Patients in severe cases may show signs of kidney failure, respiratory distress, or cardiovascular collapse.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

In patients with acute-on-chronic liver disease, physical examination findings may include:

A
  • Caput Medusae: Dilated veins around the umbilicus, indicating portal hypertension (increased pressure in the liver’s blood vessels).
  • Spider Nevi: Small, spider-like blood vessels on the skin, commonly seen in chronic liver disease.
  • Palmar Erythema: Redness of the palms, another common sign of liver disease.
  • Ascites: Fluid buildup in the abdomen, seen in advanced liver disease.
  • Dupuytren’s Contracture: Thickening of the hand tendons, associated with chronic liver disease.
  • Gynecomastia: Breast tissue enlargement in men due to hormonal imbalances in liver disease.
  • Hepatic Encephalopathy: Confusion, lethargy, and other neurological symptoms resulting from the buildup of toxins normally cleared by the liver.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Diagnosis of Acute Hepatitis and Acute Liver Failure

Markers of Hepatocyte Metabolic/Catabolic Activities
These markers reflect the liver’s metabolic and detoxifying roles and indicate dysfunction when elevated

A
  1. Elevated Serum Bilirubin:
    • Bilirubin is a breakdown product of red blood cells, normally processed by the liver and excreted in bile. Elevated levels indicate the liver’s impaired ability to clear bilirubin, leading to jaundice.
  2. Elevated Ammonia:
    • Ammonia is a waste product of protein metabolism, detoxified by the liver into urea. Increased ammonia levels indicate the liver’s inability to process toxins, which can lead to hepatic encephalopathy—a condition where toxins build up and affect the brain.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Markers Suggestive of Hepatocellular Injury
Hepatocellular injury refers to direct damage to liver cells, often indicated by elevated liver enzymes:

A
  1. Serum Transaminases (ALT and AST):
    • ALT (Alanine Aminotransferase) and AST (Aspartate Aminotransferase) are enzymes found in liver cells that are released into the blood when these cells are damaged.
    • Marked elevations (greater than five times the upper limit of normal or over 500 IU/L) suggest extensive liver damage and are seen in:
      • Drug-induced liver injury (e.g., acetaminophen overdose)
      • Severe ischemia to the liver (e.g., during shock or hypoperfusion)
      • Hepatic necrosis
      • Severe autoimmune hepatitis
    • Milder elevations (less than five times the upper limit of normal or below 500 IU/L) may indicate chronic, less acute liver damage, commonly seen in:
      • Autoimmune disorders
      • Hemochromatosis
      • Wilson disease
      • Alpha-1 antitrypsin deficiency
      • Alcoholic liver disease
      • Non-alcoholic fatty liver disease
      • Mild drug-induced liver injury
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Markers of Liver Injury Secondary to Cholestasis
Cholestasis is the impaired secretion or flow of bile, resulting in bile buildup in the liver:

A
  1. Alkaline Phosphatase (AP):
    • Elevated AP levels indicate impaired bile flow. While AP is produced in various tissues, a significant increase usually points to liver or bile duct issues.
  2. Gamma-Glutamyl Transferase (GGT):
    • GGT is another enzyme involved in bile secretion. Elevated GGT, together with AP, confirms cholestasis.
    • Causes of cholestasis include:
      • Intra-hepatic causes: Primary biliary cirrhosis, primary sclerosing cholangitis.
      • Extra-hepatic causes: Choledocholithiasis (gallstones in the bile ducts), malignancy compressing bile ducts.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Markers of Liver Synthetic Function
The liver’s synthetic function refers to its ability to produce proteins, including clotting factors, which can be impaired in liver injury:

A
  1. Elevated Prothrombin Time (PT) and International Normalized Ratio (INR):
    • PT measures the time it takes for blood to clot and is dependent on coagulation factors produced by the liver. Elevated PT or INR indicates liver damage, particularly a decreased ability to produce vitamin K-dependent clotting factors (II, VII, IX, X).
    • An INR greater than 1.5 is a key marker of acute liver failure and a poor prognostic sign. PT and INR are sensitive markers of liver function, often changing within hours to days of acute liver injury.
  2. Decreased Albumin:
    • Albumin is a protein synthesized by the liver, but its levels decrease more slowly compared to PT/INR, making it less useful in diagnosing acute liver failure. While low albumin can indicate chronic liver disease or malnutrition, it is less specific for acute hepatitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What are the Diagnostic Investigations for Acute Hepatitis and Acute Liver Failure?

A
  1. Hepatitis A IgM Antibody:
    • Detects acute infection with Hepatitis A, as IgM antibodies are produced early in the infection.
  2. Hepatitis B Panel:
    • Hepatitis B Surface Antigen (HBsAg): Indicates active infection with Hepatitis B.
    • Hepatitis B Core Antibody (IgM): Reflects recent infection with Hepatitis B.
    • Hepatitis B Surface Antibody (anti-HBs): Indicates immunity either from vaccination or past infection.
  3. Hepatitis C Antibody:
    • Detects antibodies to Hepatitis C, indicating exposure to the virus. Further tests, like RNA PCR, may confirm active infection.
  4. Iron Panel:
    • Measures serum iron, total iron-binding capacity (TIBC), serum transferrin saturation, and serum ferritin to assess iron metabolism, especially in conditions like hemochromatosis.
  5. EBV and CMV Antibodies:
    • Used to detect infections by Epstein-Barr virus and cytomegalovirus, which can cause hepatitis.
  6. Ceruloplasmin and Urine Copper:
    • These tests evaluate Wilson’s disease, a hereditary condition that leads to copper accumulation in the liver.
  7. HIV ELISA:
    • Screens for HIV infection, as HIV can indirectly cause liver dysfunction through coinfections or drug-induced liver injury.
  8. Autoimmune Markers:
    • Antinuclear Antibodies (ANA), Anti-Smooth Muscle Antibodies (ASMA), Anti-Liver/Kidney Microsomal Antibodies (LKM), and IgG levels are tested to diagnose autoimmune hepatitis.
  9. Drug Panel Test:
    • Checks for acetaminophen toxicity and other substances that may cause liver damage, along with a urine toxicology screen for illicit drugs.
  10. Doppler Study:
    - Sonographic evaluation of the hepatic, portal, and hepatic artery veins to check for vascular issues like Budd-Chiari syndrome (hepatic vein thrombosis).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What are the Imaging Studies you will also like to do?

A
  1. Abdominal Ultrasound:
    • First-line imaging for cholestasis. Biliary dilatation suggests extrahepatic causes like gallstones, while a lack of dilation points to intrahepatic issues such as drug-induced liver injury or autoimmune causes (e.g., PBC, PSC).
  2. Abdominal CT Scan / MRI:
    • More detailed imaging is performed if necessary to assess for liver lesions, tumors, or vascular complications.
  3. Chest X-ray (CXR), Electrocardiogram (ECG), Echocardiography (ECHO):
    • These tests evaluate the heart and lungs, particularly in cases where liver injury may be secondary to heart failure or shock.
  4. Full Blood Count (FBC), Electrolytes, Urea, Creatinine (EUCR), Random Blood Sugar (RBS):
    • Used to monitor overall health status and look for complications like infection or metabolic disturbances.
  5. Alpha-Fetoprotein (AFP):
    • A tumor marker used in cases of liver cancer suspicion.
  6. Urinalysis:
    • Assesses for evidence of kidney involvement or metabolic issues related to liver disease.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What are the treatments you will be considering?

A

Treatment

  1. Supportive Care:
    • Intravenous Fluids (IVF), antiemetics, analgesics, and antipruritics are given for symptom control, especially in viral hepatitis.
    • Electrolyte imbalances are corrected.
  2. Hepatotoxic Agents:
    • Patients must avoid alcohol and hepatotoxic medications or supplements.
  3. N-acetylcysteine:
    • Used for acetaminophen overdose and other causes of acute liver failure.
  4. Immunosuppressants:
    • Methylprednisolone, prednisolone, and azathioprine are used in autoimmune hepatitis.
  5. Liver Transplantation:
    • This is considered for patients with acute liver failure who meet transplant criteria.
  6. Pregnancy-Related Hepatitis:
    • Fetal delivery is the treatment of choice for causes like HELLP syndrome or acute fatty liver of pregnancy.
  7. Cardiogenic Shock or Heart Failure:
    • Inotropes and diuretics are administered.
  8. Budd-Chiari Syndrome:
    • Treated with heparin (anticoagulation) or Transjugular Intrahepatic Portosystemic Shunt (TIPSS).
  9. Wilson’s Disease:
    • Treated with zinc, penicillamine, or triamterine.
  10. Hemochromatosis:
    • Managed with phlebotomy or iron chelators like deferoxamine.
  11. Mushroom Poisoning (Amanita phalloides):
    • Treated with IV fluids, gastric lavage, N-acetylcysteine, silibinin, and IV penicillin G.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Monitoring

  • Continuous monitoring of liver function tests (LFTs) is essential to assess treatment response and detect deterioration early in cases of acute liver failure
A
31
Q

What’s the prognosis of acute hepatitis?

A

Prognosis of Acute Hepatitis

The prognosis of acute hepatitis is highly dependent on the underlying cause of the liver injury. Timely identification and treatment of the causative agent are critical to improving patient outcomes and reducing complications. For example, acute viral hepatitis or drug-induced hepatitis can have different prognostic outcomes based on early detection and intervention. Early treatment can prevent progression to acute liver failure (ALF) and reduce both morbidity and mortality rates

32
Q

What are the Complications of Acute Hepatitis

A
  1. Acute Liver Failure (ALF): This is the most severe complication of acute hepatitis and can develop rapidly, characterized by the sudden onset of liver dysfunction, jaundice, coagulopathy, and hepatic encephalopathy.
  2. Coagulopathy: Due to the liver’s role in producing clotting factors, injury can result in bleeding disorders, manifesting as an elevated International Normalized Ratio (INR).
  3. Hepatic Encephalopathy: A decline in brain function due to the liver’s inability to remove toxins from the blood, leading to confusion, altered mental status, and in severe cases, coma.
  4. Need for Liver Transplantation: In cases where the liver damage is irreversible or when patients meet criteria for acute liver failure, a liver transplant may be the only life-saving option.
  5. Infections: The immunosuppressive effects of liver failure can lead to increased susceptibility to infections, both bacterial and viral.
33
Q

Prevention of Acute Hepatitis

A
  1. Vaccinations: Vaccines are available for Hepatitis A, B, and E, which can prevent many cases of acute viral hepatitis.
  2. Hygiene Measures: Improving food safety, ensuring water purification, and practicing good hygiene can reduce the risk of viral transmission, especially in areas where Hepatitis A and E are endemic.
  3. Safe Practices:
    • Avoiding intravenous (IV) drug use and practicing safe sex can prevent Hepatitis B and C.
    • Safe handling of blood and blood products through rigorous screening is important to avoid transmission of Hepatitis B and C.
  4. Safe Storage and Use of Acetaminophen:
    • For children, storing medications out of their reach and using childproof packaging can prevent accidental toxic ingestion.
    • For adults, public education on the dangers of excessive acetaminophen use, including its presence in over-the-counter medications, is crucial in preventing unintentional overdose.
  5. Health Education: Educating the public about liver disease, especially in terms of prevention and early detection, can significantly reduce the risk of acute hepatitis progression
34
Q

What’s Acute Liver Failure (ALF)

A

Definition:
Acute liver failure is a life-threatening condition characterized by the rapid deterioration of liver function in individuals without pre-existing liver disease

35
Q

This condition ALF is marked by:

A

.
- Jaundice (yellowing of the skin and eyes),
- Coagulopathy (INR > 1.5),
- Hepatic Encephalopathy (neurological dysfunction due to liver failure).

If these symptoms develop in a patient with pre-existing liver disease, it is termed acute-on-chronic liver failure.

36
Q

Though acute liver failure is rare, it is one of the most serious complications of acute hepatitis, requiring immediate medical intervention.

A
37
Q

What are the Classification of Acute Liver Failure

A
  1. By Interval from Jaundice to Hepatic Encephalopathy:
    • Hyperacute: Development of hepatic encephalopathy within 7 days after the onset of jaundice.
    • Acute: Encephalopathy occurs between 8 and 28 days after jaundice onset.
    • Subacute: Encephalopathy develops between 29 days and 12 weeks after the onset of jaundice.
  2. By Interval from Hepatic Illness to Hepatic Encephalopathy:
    • Fulminant ALF: Occurs within 8 weeks of the onset of hepatic illness.
    • Late-Onset ALF: Develops between 8 and 26 weeks after the onset of hepatic illness.
38
Q

Early identification and classification of ALF are important for deciding the appropriate course of treatment, including whether a liver transplant is necessary.

A
39
Q

The progression from acute hepatitis to acute liver failure varies significantly depending on the underlying cause such as? With its percentage

A
  • Hepatitis A: Less than 1% of patients with acute hepatitis A progress to ALF.
  • Hepatitis B: About 1% of patients with acute hepatitis B may progress to ALF.
  • Hepatitis E: In developing countries, 20-40% of patients with acute hepatitis E progress to ALF, making it a significant cause.
  • Autoimmune Hepatitis: Around 69% of patients with severe autoimmune hepatitis can develop ALF.
  • Wilson Disease: Approximately 2% of ALF cases are attributed to Wilson disease
40
Q

In high-resource countries like the US and Europe, acetaminophen (paracetamol) hepatotoxicity and idiosyncratic drug reactions account for 40-50% of ALF cases. However, in low-resource settings, viral infections are the leading cause.

  • About 45-55% of patients with ALF recover spontaneously, while 25% require liver transplantation, and the remaining 25% succumb to the illness.
  • 75% of patients with acetaminophen-induced ALF recover spontaneously, while only 40% recover from ALF caused by other etiologies
A
41
Q

What’s the Pathophysiology of Acute Liver Failure

A

ALF typically results from massive hepatocyte necrosis, which may progress to organ failure. Both necrosis and apoptosis of liver cells can occur simultaneously, leading to:
- Elevated serum levels of tumor necrosis factor-alpha (TNF-α), interleukin-1 (IL-1), and interleukin-6 (IL-6).
- Hyperammonemia, which causes cerebral edema through cytotoxic and vasogenic mechanisms, leading to brain swelling and impaired neurological function.
- A decrease in complement synthesis, impairing the clearance of immune complexes and activation of B cells.

In acetaminophen (paracetamol) overdose, a toxic metabolite called N-acetyl-p-benzoquinone imine (NAPQI) is generated through the P450 enzyme pathway. Normally, this metabolite is neutralized by glutathione. However, in overdose cases, glutathione is depleted, causing direct hepatocyte injury from NAPQI buildup.

42
Q

Etiology of Acute Liver Failure

The causes of ALF often overlap with those of acute hepatitis, including viral infections, drug-induced liver injury, autoimmune hepatitis, metabolic disorders (e.g., Wilson disease), and ischemic hepatitis.

A
43
Q

What are the Clinical Features of Acute Liver Failure

A
  • Cerebral Edema: Signs include papilledema, hypertension, bradycardia, abnormal pupillary reflexes, muscular rigidity, and decerebrate posturing in advanced stages.
  • Hepatic Encephalopathy: This is a hallmark of ALF and encompasses a spectrum of neurological and psychiatric changes.
44
Q

Use The West Haven Criteria to grade the severity of ALF

A
  • Grade 1: Subtle changes such as altered sleep patterns, impaired concentration, mood changes, but oriented in time and space.
    • Grade 2: Lethargy, apathy, disorientation in time, personality changes, inappropriate behavior, and asterixis (flapping tremor).
    • Grade 3: Severe confusion, somnolence, bizarre behavior, and physical findings like hyper-reflexia, nystagmus, clonus, and rigidity.
    • Grade 4: Coma.
45
Q

Investigations for Acute Liver Failure

Investigations for ALF are similar to those for acute hepatitis, focusing on liver function and the identification of the underlying cause. These include:
- Septic workup: Blood cultures, microscopy, culture, and sensitivity (MCS) tests to rule out infection.

Additional tests include markers of liver injury, imaging studies like ultrasound, CT scan, and MRI, and other tests to evaluate systemic complications such as coagulopathy or hepatic encephalopathy.

A
46
Q

Treatment of Acute Liver Failure
How do you manage ALF?
requires intensive care with a multidisciplinary approach for the best possible outcomes. This includes

A
  1. Airway Management:
    • In cases of severe encephalopathy or respiratory compromise, airway support may be needed, which can involve:
      • Oropharyngeal airway to maintain airway patency.
      • Nasogastric tube (NGT) for stomach decompression.
      • Endotracheal intubation for patients with deteriorating mental status.
  2. Breathing Support:
    • Oxygen may need to be administered depending on the severity of respiratory compromise.
  3. Circulation Management:
    • Fluid management is critical in maintaining hemodynamic stability.
    • Crystalloids are the preferred fluids, but careful monitoring is needed to prevent fluid overload.
    • Dopamine or norepinephrine may be used to manage hypotension caused by circulatory collapse.
  4. Management of Encephalopathy and Cerebral Edema:
    • Regular mental status checks are important to monitor the progression of hepatic encephalopathy, especially once patients reach Grade 2 encephalopathy.
    • Sedatives should be avoided as they can worsen encephalopathy.
    • Head elevation (30°) to reduce intracranial pressure.
    • Lactulose is administered to lower ammonia levels and manage encephalopathy.
    • Intracranial hypertension is managed with:
      • Mannitol and hypertonic saline to reduce brain swelling.
      • Hyperventilation to lower intracranial pressure by reducing carbon dioxide levels.
      • Barbiturates and hypothermia as adjuncts for refractory cases.
  5. Management of Coagulopathy and Bleeding:
    • Correct clotting abnormalities only when an invasive procedure is planned or INR >7.
    • Platelet transfusion is given if:
      • Platelet count is <10,000/uL (spontaneous bleeding risk).
      • Platelet count <50,000/uL (if an invasive procedure is planned).
    • Blood transfusion is required if gastrointestinal bleeding occurs.
    • IV Proton Pump Inhibitors (PPIs) are administered prophylactically to prevent stress ulcers.
  6. Diet:
    • An NGT should be passed for feeding unless the patient has a paralytic ileus.
    • Large amounts of IV glucose should be given to prevent or manage hypoglycemia.
  7. Infection Surveillance:
    • Ongoing monitoring for bacterial and fungal infections is essential, especially in cases with:
      • Progressive encephalopathy.
      • Signs of systemic inflammatory response syndrome (SIRS).
      • Persistent hypotension.
  8. Liver Transplantation:
    • Liver transplantation is considered for patients with severe ALF who meet the King’s College Hospital criteria. This may be the only definitive treatment for patients who do not recover spontaneously.
47
Q

What are the Complications of Acute Liver Failure

A
  • Seizures.
  • Hemorrhage due to coagulopathy.
  • Infections (bacterial and fungal).
  • Renal failure (often due to hepatorenal syndrome).
  • Metabolic and electrolyte imbalances such as:
    • Hyponatremia.
    • Hypokalemia.
    • Hypoglycemia.
    • Metabolic acidosis.
    • Hypophosphatemia.
  • Disseminated intravascular coagulopathy (DIC).
  • Acute respiratory distress syndrome (ARDS).
48
Q

Prevention of Acute Liver Failure
How?

A
  1. Education:
    • Patient, pharmacy, and physician education about the risks of overuse of paracetamol (acetaminophen) is crucial.
    • Clear guidelines on avoiding the prescription of multiple paracetamol-containing preparations and exceeding maximum daily doses are necessary.
  2. Vaccination:
    • Vaccination for Hepatitis A, B, and E can help prevent viral-related ALF.
  3. Preemptive Antiviral Therapy:
    • In hepatitis B carriers, preemptive antiviral therapy can reduce the risk of acute liver failure.
  4. Health Education:
    • Public health education to reduce risky behaviors such as IV drug use, unsafe sex practices, and harmful traditional practices.
    • Improving personal hygiene, environmental sanitation, food handling, and ensuring access to safe drinking water can reduce the incidence of viral hepatitis, especially in low-resource settings
49
Q

What’s the King’s College Hospital Criteria for Liver Transplantation in Acute Liver Failure

The King’s College Hospital criteria are widely used to determine the need for liver transplantation in patients with acute liver failure (ALF). These criteria differ based on the cause of liver failure—acetaminophen-related or non-acetaminophen-related.

A

Acetaminophen-Induced Acute Liver Failure

Patients with acetaminophen (paracetamol) toxicity are considered for liver transplantation if they meet any of the following:

  1. Arterial pH < 7.3 (metabolic acidosis despite adequate fluid resuscitation).
  2. Prothrombin time > 100 seconds (severe coagulopathy).
  3. Serum creatinine > 3.4 mg/dL (300 μmol/L), in patients with Grade III or IV hepatic encephalopathy (severe encephalopathy).

For liver failure caused by factors other than acetaminophen, transplantation is considered if the patient meets any of the following:

  1. Prothrombin time > 100 seconds (severe coagulopathy).

OR

  1. Presence of three of the following variables:
    • Age < 10 years or > 40 years.
    • Cause: The etiology includes non-A, non-B hepatitis, halothane-induced hepatitis, or idiosyncratic drug reactions.
    • Duration of jaundice before the onset of encephalopathy is greater than 7 days.
    • Prothrombin time > 50 seconds (moderate coagulopathy).
    • Serum bilirubin > 17.6 mg/dL (300 μmol/L) (severe hyperbilirubinemia).

These criteria help guide clinicians in identifying which patients are at higher risk of poor outcomes and thus may benefit from early referral for liver transplantation.

50
Q
  1. Describe the etiology and pathophysiology of acute hepatitis.
A

Acute hepatitis refers to the rapid onset of liver inflammation. The etiology can be classified into viral, toxic, autoimmune, or ischemic causes.

  • Viral hepatitis: The most common cause. Hepatitis viruses (A, B, C, D, and E) attack hepatocytes, causing inflammation. Hepatitis A and E are transmitted via the fecal-oral route and are typically self-limiting. Hepatitis B and C, transmitted via blood and body fluids, can lead to both acute and chronic hepatitis. Viral replication triggers immune responses, which cause hepatocyte injury and apoptosis.
  • Toxic hepatitis: Certain drugs (e.g., acetaminophen in overdose), alcohol, and toxins can cause direct hepatocyte injury. For example, acetaminophen toxicity leads to hepatocyte necrosis due to the accumulation of toxic metabolites (NAPQI), which depletes glutathione and causes oxidative stress.
  • Autoimmune hepatitis: In some individuals, autoimmunity against liver cells results in inflammation. The exact cause is unknown, but it’s associated with other autoimmune diseases. Autoantibodies such as anti-nuclear antibodies (ANA) and anti-smooth muscle antibodies (ASMA) target hepatocytes, leading to immune-mediated damage.
  • Ischemic hepatitis: Reduced blood flow to the liver, often due to heart failure or shock, results in hepatocyte death secondary to hypoxia. This is known as “shock liver.”

Pathophysiologically, hepatocyte injury triggers the release of liver enzymes (e.g., ALT, AST), which are elevated in the blood. The liver’s ability to perform vital functions—like detoxification, synthesis of proteins (e.g., albumin, clotting factors), and metabolism of bilirubin—is impaired, leading to jaundice, coagulopathy, and encephalopathy

51
Q
  1. Compare and contrast acute hepatitis and chronic hepatitis in terms of clinical presentation, causes, and prognosis.
A

Acute and chronic hepatitis differ primarily in duration, symptoms, and long-term outcomes:

  • Acute hepatitis:
    • Duration: Lasts less than 6 months.
    • Symptoms: Sudden onset of symptoms, which can include fever, malaise, fatigue, jaundice, and abdominal pain. Symptoms are typically more dramatic and develop rapidly over days to weeks.
    • Causes: Mainly viral infections (HAV, HBV, HEV), drugs, toxins, or autoimmune conditions.
    • Prognosis: Most cases of acute hepatitis resolve spontaneously, especially viral forms like hepatitis A and E. However, certain types (e.g., fulminant hepatitis) can progress to acute liver failure, which is life-threatening.
  • Chronic hepatitis:
    • Duration: Persists for more than 6 months.
    • Symptoms: Symptoms are more subtle and progress slowly, often manifesting as fatigue, mild jaundice, and nonspecific complaints. In advanced stages, it can progress to cirrhosis and liver failure.
    • Causes: Commonly due to hepatitis B or C infections, alcohol abuse, or autoimmune diseases.
    • Prognosis: Chronic hepatitis can lead to fibrosis, cirrhosis, and an increased risk of hepatocellular carcinoma (HCC). Treatment is often long-term and focused on slowing disease progression (e.g., antiviral therapy for hepatitis B or C).
52
Q
  1. Outline the clinical features and diagnosis of acute liver failure.
A

Acute liver failure (ALF) is characterized by the rapid onset of severe liver dysfunction in a previously healthy individual, typically within days to weeks. The hallmark features are:

  • Jaundice: Due to impaired bilirubin metabolism.
  • Coagulopathy: Reduced production of clotting factors, leading to prolonged PT/INR and bleeding tendencies.
  • Hepatic encephalopathy: Results from the buildup of toxins (e.g., ammonia) that affect brain function. Symptoms range from confusion and disorientation to coma.
  • Other features: Hypoglycemia (due to decreased gluconeogenesis), ascites, and multi-organ dysfunction may occur.

Diagnosis of ALF is based on the following criteria:
- Liver function tests: Markedly elevated ALT and AST levels (often >1000 U/L), with elevated bilirubin and prolonged PT/INR.
- Hepatic encephalopathy: Clinical grading from mild confusion (grade I) to coma (grade IV).
- Imaging and biopsy: May show liver parenchymal changes like hepatocyte necrosis or steatosis, depending on the cause

53
Q
  1. Discuss the causes of acute liver failure, including the role of acetaminophen overdose.
A

The causes of acute liver failure (ALF) can be grouped into:

  • Drug-induced liver injury (DILI): The most common cause, particularly from acetaminophen overdose. Acetaminophen is metabolized by the liver into a toxic metabolite (NAPQI). In overdose, glutathione stores are depleted, leading to hepatocyte necrosis. The risk is higher in chronic alcohol users and those with pre-existing liver disease.
  • Viral hepatitis: Hepatitis A, B, D, and E can lead to fulminant hepatitis. Hepatitis B and D co-infections are particularly dangerous.
  • Autoimmune hepatitis: A rapid immune attack against liver cells can result in ALF if untreated.
  • Ischemic hepatitis: A result of hypoperfusion due to cardiac arrest, shock, or severe heart failure.
  • Wilson’s disease: A rare cause of ALF, due to copper accumulation in the liver, leading to extensive damage
54
Q
  1. Explain the management of acute liver failure, focusing on supportive care and specific treatments.
A

The management of acute liver failure involves supportive care and specific treatment based on the cause:

  • Supportive care:
    • ICU admission: Patients need intensive monitoring of liver function, coagulation status, and neurological status.
    • Management of complications: Encephalopathy is treated by reducing ammonia levels (lactulose), and coagulopathy may require fresh frozen plasma. Hypoglycemia is corrected with IV dextrose.
  • Specific treatments:
    • Acetaminophen toxicity: N-acetylcysteine (NAC) is the antidote and should be administered as early as possible.
    • Viral hepatitis: Antiviral medications may be used in cases of hepatitis B, but supportive care remains essential.
    • Liver transplant: For irreversible liver damage, transplantation is the only definitive treatment
55
Q
  1. Outline the complications of acute liver failure and their clinical implications.
A

Acute liver failure can lead to a range of life-threatening complications:

  • Cerebral edema and herniation: This is the most feared complication, particularly in advanced encephalopathy. It results from increased intracranial pressure due to ammonia buildup.
  • Sepsis: Patients with ALF are prone to infections due to impaired immune function.
  • Renal failure (hepatorenal syndrome): ALF often leads to kidney failure due to poor renal perfusion and the toxic effects of accumulated substances.
  • Multi-organ failure: ALF affects multiple organ systems, leading to cardiac, pulmonary, and renal dysfunction
56
Q
  1. Discuss the role of liver transplantation in the management of acute liver failure.
A

Liver transplantation is often the only curative treatment for patients with irreversible acute liver failure:

  • Indications: Transplantation is considered for patients who meet specific criteria (King’s College Criteria), such as those with severe encephalopathy, prolonged INR, and severe metabolic disturbances.
  • Prognosis post-transplant: Survival rates after liver transplantation for ALF are high, but the procedure is risky and requires careful donor matching and post-operative care to prevent rejection and infection.
57
Q
  1. Describe the pathophysiology of acute hepatitis, highlighting the role of the immune response and viral infections.
A

Acute hepatitis is an inflammation of the liver that occurs over a short duration (weeks to a few months). The pathophysiology involves direct liver cell injury and an immune-mediated response.

  • Viral infections: The most common causes of acute hepatitis are viral infections such as hepatitis A, B, C, D, and E viruses. In viral hepatitis, hepatocytes (liver cells) are infected by the virus, leading to their injury or destruction. Hepatitis B and C can result in a more prolonged immune response, leading to chronic hepatitis.
  • Immune response: The body’s immune system attempts to fight off the virus, but in doing so, it attacks the liver cells, causing inflammation. Cytotoxic T-cells (CD8+ T cells) and natural killer (NK) cells are the primary mediators of this immune attack on infected liver cells. This process leads to hepatocyte necrosis and apoptosis.
  • Cytokines: The immune response also involves the release of cytokines (e.g., TNF-α, IL-1), which promote inflammation and recruit more immune cells to the liver. However, these cytokines can also exacerbate liver damage.
  • Histological changes: The liver in acute hepatitis shows ballooning degeneration, Councilman bodies (apoptotic hepatocytes), and infiltration of inflammatory cells (mainly lymphocytes).
  • Other causes: Acute hepatitis can also be caused by toxins (e.g., alcohol, drugs like acetaminophen), ischemia, or autoimmune hepatitis. These forms of hepatitis follow similar mechanisms of hepatocyte injury, but they are not related to infectious agents
58
Q
  1. Explain the clinical features of acute liver failure and how they differ from those of acute hepatitis.
A

Acute liver failure (ALF) occurs when the liver loses its function rapidly (over days to weeks), often following acute hepatitis or drug-induced liver injury. It is characterized by:

  • Encephalopathy: One of the hallmark signs of ALF is hepatic encephalopathy, where the liver’s inability to detoxify harmful substances leads to the buildup of toxins (e.g., ammonia) in the bloodstream, affecting the brain. This presents as confusion, altered mental status, and even coma in severe cases.
  • Coagulopathy: The liver produces clotting factors, so in ALF, there is a marked reduction in clotting factor synthesis, leading to an increased risk of bleeding (measured by an elevated International Normalized Ratio, or INR).
  • Jaundice: Both acute hepatitis and ALF may present with jaundice (yellowing of the skin and eyes), but in ALF, the jaundice is often more severe due to extensive hepatocyte damage and cholestasis (bile flow obstruction).
  • Multisystem involvement: ALF is often associated with multiorgan dysfunction, including renal failure (hepatorenal syndrome), circulatory collapse (hypotension), and respiratory failure (acute respiratory distress syndrome, ARDS).
  • Progression: While acute hepatitis may resolve spontaneously or progress to chronic hepatitis, ALF is a life-threatening condition requiring urgent medical intervention, including liver transplantation
59
Q
  1. Discuss the causes and risk factors of drug-induced liver injury leading to acute liver failure.
A

Drug-induced liver injury (DILI) is one of the most common causes of acute liver failure. The mechanisms and risk factors include:

  • Acetaminophen toxicity: Acetaminophen (paracetamol) overdose is the leading cause of DILI and acute liver failure in many countries. Normally, acetaminophen is metabolized in the liver, but in overdose situations, the liver’s detoxification pathways are overwhelmed, leading to the formation of a toxic metabolite (NAPQI). NAPQI depletes glutathione, leading to oxidative stress and hepatocyte necrosis.
  • Idiosyncratic reactions: Some drugs cause unpredictable liver injury through idiosyncratic mechanisms, which are not dose-related and occur in susceptible individuals. Drugs such as antibiotics (e.g., amoxicillin-clavulanate), antiepileptics (e.g., phenytoin), and statins can cause idiosyncratic DILI.
  • Risk factors for DILI:
    • Genetic susceptibility: Polymorphisms in drug-metabolizing enzymes (e.g., CYP450) increase the risk of hepatotoxicity in certain individuals.
    • Age and gender: Older age and female gender are associated with an increased risk of DILI.
    • Alcohol use: Chronic alcohol consumption enhances the toxicity of some drugs, like acetaminophen, by upregulating CYP450 enzymes and depleting glutathione.
    • Preexisting liver disease: Individuals with underlying liver diseases (e.g., hepatitis B or C) are more susceptible to DILI
60
Q
  1. Outline the diagnostic approach for a patient presenting with acute hepatitis, including relevant laboratory investigations and imaging studies.
A

The diagnosis of acute hepatitis involves a combination of clinical history, physical examination, laboratory tests, and imaging studies:

  • History and physical exam: The patient’s history may reveal risk factors such as recent travel, alcohol use, drug ingestion, or viral exposure. Symptoms include jaundice, fatigue, nausea, vomiting, and right upper quadrant abdominal pain.
  • Laboratory tests:
    • Liver function tests (LFTs): Elevated levels of aminotransferases (AST and ALT) are typical of acute hepatitis, indicating hepatocyte injury. ALT is more specific to the liver. Bilirubin levels are often elevated, reflecting impaired bilirubin metabolism.
    • Prothrombin time (PT)/INR: An elevated INR suggests impaired liver synthetic function, which is more common in severe cases or progression to acute liver failure.
    • Viral serology: Testing for viral hepatitis (e.g., hepatitis A IgM, hepatitis B surface antigen, hepatitis C antibodies) helps determine the etiology.
    • Autoimmune markers: In cases where autoimmune hepatitis is suspected, antinuclear antibodies (ANA), anti-smooth muscle antibodies (SMA), and immunoglobulin G (IgG) levels may be elevated.
  • Imaging:
    • Ultrasound: A liver ultrasound can help rule out biliary obstruction, hepatic vein thrombosis (Budd-Chiari syndrome), or other structural abnormalities.
    • CT or MRI: In certain cases, these imaging modalities can provide more detailed information about liver architecture and surrounding structures
61
Q
  1. Discuss the treatment options for acute liver failure, including both medical and surgical interventions.
A

Management of acute liver failure is centered around supportive care and addressing the underlying cause. Treatments include:

  • Supportive care:
    • ICU monitoring: Patients with ALF require admission to the intensive care unit due to the risk of rapid deterioration.
    • Correction of coagulopathy: Fresh frozen plasma (FFP) and vitamin K may be administered to correct coagulation abnormalities. However, liver transplantation is the definitive treatment for severe cases.
    • Management of encephalopathy: Lactulose and rifaximin are used to reduce ammonia levels in hepatic encephalopathy.
    • Hemodynamic support: Intravenous fluids and vasopressors (e.g., norepinephrine) may be necessary to maintain blood pressure.
  • Specific therapies:
    • Acetaminophen toxicity: Intravenous N-acetylcysteine (NAC) is the antidote for acetaminophen-induced liver injury and can be life-saving if administered early.
    • Antiviral therapy: In cases of acute hepatitis B or C leading to ALF, antiviral therapy (e.g., tenofovir or entecavir for HBV) may be indicated.
  • Liver transplantation: For patients with fulminant hepatic failure who do not respond to medical therapy, liver transplantation is the only definitive treatment. Selection criteria include a rapidly deteriorating condition, worsening encephalopathy, and failure of the liver to recover within a specified time frame
62
Q
  1. Explain the prognosis and possible outcomes of acute hepatitis and acute liver failure.
A
  • Acute hepatitis prognosis:
    • Many cases of acute viral hepatitis (e.g., hepatitis A) resolve spontaneously with supportive care, and the liver function normalizes over time.
    • However, hepatitis B and C may progress to chronic hepatitis and increase the risk of cirrhosis and hepatocellular carcinoma (HCC) in the long term.
  • Acute liver failure prognosis:
    • The prognosis of ALF depends on the underlying cause and the rapidity of treatment. Acetaminophen-induced ALF has a relatively favorable prognosis if treated early with NAC.
    • The King’s College Criteria is often used to predict mortality and determine the need for liver transplantation. Indicators of poor prognosis include severe coagulopathy (INR > 6.5), high bilirubin levels, and grade III-IV hepatic encephalopathy
63
Q
  1. Describe the complications of acute liver failure, focusing on multi-organ involvement.
A

Acute liver failure often results in complications involving multiple organs:

  • Hepatic encephalopathy: Ammonia and other toxins accumulate in the blood, crossing the blood-brain barrier and leading to cerebral edema, confusion, and coma.
  • Coagulopathy and bleeding: The liver’s inability to synthesize clotting factors results in spontaneous bleeding (e.g., gastrointestinal bleeding) and a prolonged INR.
  • Renal failure (hepatorenal syndrome): ALF can lead to kidney dysfunction due to alterations
64
Q

Question 3: Evaluate the role of the King’s College Hospital criteria in predicting outcomes and guiding liver transplantation in ALF.

A

The King’s College Hospital criteria play a crucial role in predicting outcomes for patients with acute liver failure (ALF) and help guide decisions on liver transplantation. These criteria differ for acetaminophen-related and non-acetaminophen-related ALF.

  • For acetaminophen-induced ALF, criteria include pH <7.3, INR >100 seconds, serum creatinine >3.4 mg/dL, and encephalopathy (Grade III/IV).
  • For non-acetaminophen-induced ALF, the criteria are broader, factoring in age (<10 or >40 years), cause of hepatitis (non-A, non-B, idiosyncratic drug reaction), and jaundice duration before encephalopathy (>7 days).

By meeting specific thresholds, these criteria help stratify patients who are unlikely to recover spontaneously and may require urgent liver transplantation. Liver transplant significantly improves survival in patients with severe ALF. The criteria are reliable but should always be considered in conjunction with clinical judgment, as some patients who do not meet the criteria may still deteriorate and require a transplant

65
Q

Question 4: Evaluate the complications of acute liver failure, focusing on their impact on prognosis and management.

A

Acute liver failure (ALF) has several life-threatening complications that significantly affect prognosis and management strategies:

  • Cerebral edema is a critical complication, especially in advanced hepatic encephalopathy, leading to increased intracranial pressure and risk of brain herniation. It requires immediate management with mannitol, hypertonic saline, or hyperventilation to reduce pressure.
  • Coagulopathy results from impaired clotting factor production by the liver, manifesting as bleeding tendencies or disseminated intravascular coagulation (DIC). While transfusions of platelets or fresh frozen plasma may be necessary, correcting clotting abnormalities is generally reserved for situations involving active bleeding or invasive procedures.
  • Renal failure, particularly hepatorenal syndrome, is common in ALF and may require renal replacement therapy (e.g., dialysis) to stabilize patients.
  • Infections (bacterial or fungal) due to immunosuppression often complicate ALF and may worsen hepatic encephalopathy. Empiric antibiotics and antifungals are often indicated in critically ill patients.
  • Hypoglycemia and electrolyte disturbances such as hyponatremia, hypokalemia, and metabolic acidosis are frequently seen and require close monitoring and correction.

These complications worsen outcomes, increase the need for intensive care, and often necessitate liver transplantation when survival is otherwise unlikely

66
Q

Question 5: Explain the role of immune response and systemic inflammation in the progression of acute hepatitis to acute liver failure.

A

The progression of acute hepatitis to acute liver failure (ALF) involves a combination of immune-mediated hepatocyte damage and systemic inflammation.

  • Cytokines, such as TNF-α, IL-1, and IL-6, play a central role in promoting inflammation and hepatocyte apoptosis. These cytokines are elevated in ALF, contributing to immune system activation and the destruction of liver cells.
  • Hepatocyte necrosis and apoptosis occur due to immune responses against infected or damaged cells. This leads to a rapid loss of functional liver mass, impairing the liver’s ability to detoxify harmful substances, produce clotting factors, and maintain metabolic homeostasis.
  • Hyperammonemia, a byproduct of impaired liver detoxification, causes cerebral edema by disrupting the blood-brain barrier, leading to hepatic encephalopathy.
  • In acetaminophen-induced ALF, the NAPQI metabolite produced during drug metabolism overwhelms glutathione stores, leading to direct hepatocyte injury. The immune system exacerbates this damage by targeting necrotic cells
67
Q
  1. What are the most common viral causes of acute hepatitis?
A

The most common viral causes of acute hepatitis include Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis D, and Hepatitis E. Among these, Hepatitis A and E are transmitted via the fecal-oral route, while Hepatitis B, C, and D are transmitted through blood and bodily fluids. Hepatitis A and E typically cause self-limiting acute infections, whereas Hepatitis B and C can lead to chronic hepatitis if not resolved

68
Q
  1. What is fulminant hepatitis, and how does it relate to acute liver failure?
A

Fulminant hepatitis is a severe and rapidly progressing form of hepatitis that leads to acute liver failure (ALF) within days to weeks. It is characterized by the sudden onset of liver dysfunction, including coagulopathy, jaundice, and encephalopathy, in the absence of pre-existing liver disease. Common causes include viral hepatitis, drug toxicity (especially acetaminophen overdose), and autoimmune hepatitis

69
Q
  1. What is the significance of elevated ALT and AST levels in acute hepatitis?
A

In acute hepatitis, elevated levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) indicate hepatocyte injury and inflammation. ALT is more liver-specific, while AST can be elevated in other tissue damage. In acute liver injury, levels of both enzymes can rise dramatically, often into the thousands of units per liter, reflecting the extent of liver damage

70
Q
  1. What is the most common cause of drug-induced acute liver failure?
A

The most common cause of drug-induced acute liver failure is acetaminophen (paracetamol) overdose. Acetaminophen in excess produces a toxic metabolite (NAPQI) that overwhelms the liver’s ability to detoxify it, leading to hepatocyte necrosis and liver failure. Early administration of N-acetylcysteine (NAC) can prevent liver damage by replenishing glutathione stores

71
Q
  1. How does acute hepatitis present clinically?
A

Patients with acute hepatitis typically present with nonspecific symptoms like fatigue, malaise, nausea, and anorexia, followed by jaundice, dark urine, and pale stools. They may also experience right upper quadrant pain due to liver inflammation. In severe cases, signs of liver dysfunction such as bleeding tendencies and encephalopathy may develop

72
Q
  1. What is the role of N-acetylcysteine in managing acetaminophen toxicity?
A

N-acetylcysteine (NAC) is the antidote for acetaminophen overdose. It works by replenishing intracellular glutathione, which helps detoxify the harmful metabolite NAPQI that accumulates after acetaminophen overdose. Administering NAC early significantly reduces the risk of acute liver failure and improves survival

73
Q
  1. What are the main complications of acute liver failure?
A

The main complications of acute liver failure (ALF) include hepatic encephalopathy (ranging from confusion to coma), cerebral edema, coagulopathy (resulting in bleeding), renal failure (hepatorenal syndrome), and sepsis. These complications can be life-threatening and require immediate medical intervention

74
Q
  1. What criteria are used to determine if a patient with acute liver failure requires a liver transplant?
A

The King’s College Criteria are widely used to determine the need for liver transplantation in patients with acute liver failure. These criteria include factors like prolonged INR, the degree of encephalopathy, and the underlying cause of liver failure (e.g., acetaminophen toxicity). If the criteria are met, the likelihood of survival without a transplant is low, and urgent transplantation is recommended